GNRH1 and metastatic prostate carcinoma: Oh et al. [22] identified newly diagnosed metastatic prostate cancer patients treated at the Veterans Affairs Hospitals from 2001 to 2004 with LHRH agonists with or without prior antiandrogen therapy.